BR0312393A - Tratamento de infertilidade com exemestano - Google Patents
Tratamento de infertilidade com exemestanoInfo
- Publication number
- BR0312393A BR0312393A BR0312393-6A BR0312393A BR0312393A BR 0312393 A BR0312393 A BR 0312393A BR 0312393 A BR0312393 A BR 0312393A BR 0312393 A BR0312393 A BR 0312393A
- Authority
- BR
- Brazil
- Prior art keywords
- exemestane
- infertility treatment
- infertility
- treatment
- administering
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
"TRATAMENTO DE INFERTILIDADE COM EXEMESTANO". A presente invenção refere-se a um método de terapia para tratamento de infertilidade em um hospedeiro feminino, compreendendo a adminsitração de uma quantidade eficaz de estimulação folicular ovariana de exemestano.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39332002P | 2002-07-02 | 2002-07-02 | |
PCT/US2003/016252 WO2004004634A2 (en) | 2002-07-02 | 2003-07-02 | Infertility treatment with exemestane |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0312393A true BR0312393A (pt) | 2005-04-12 |
Family
ID=30115565
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0312393-6A BR0312393A (pt) | 2002-07-02 | 2003-07-02 | Tratamento de infertilidade com exemestano |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1531829A2 (pt) |
JP (1) | JP2005536490A (pt) |
KR (1) | KR20050077045A (pt) |
CN (1) | CN1665516A (pt) |
AU (1) | AU2003247404A1 (pt) |
BR (1) | BR0312393A (pt) |
CA (1) | CA2491372A1 (pt) |
IL (1) | IL165813A0 (pt) |
MX (1) | MXPA05000251A (pt) |
PL (1) | PL373219A1 (pt) |
WO (1) | WO2004004634A2 (pt) |
ZA (1) | ZA200410135B (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102432156B1 (ko) * | 2020-05-18 | 2022-08-11 | 제주대학교 산학협력단 | 화학물질을 포함하는 어류의 성 성숙 제어용 조성물 및 이를 이용한 어류의 성 성숙 제어방법 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1383578E (pt) * | 2001-04-17 | 2008-10-08 | Ares Trading Sa | Inibidor da aromatase em dose única para tratamento da infertilidade |
NZ528501A (en) * | 2001-04-17 | 2008-04-30 | Ares Trading Sa | Aromatase inhibition to enhance assisted reproduction |
-
2003
- 2003-07-02 CN CN038157306A patent/CN1665516A/zh active Pending
- 2003-07-02 JP JP2004519563A patent/JP2005536490A/ja active Pending
- 2003-07-02 KR KR1020057000051A patent/KR20050077045A/ko not_active Application Discontinuation
- 2003-07-02 WO PCT/US2003/016252 patent/WO2004004634A2/en active Application Filing
- 2003-07-02 PL PL03373219A patent/PL373219A1/xx not_active Application Discontinuation
- 2003-07-02 EP EP03762980A patent/EP1531829A2/en not_active Withdrawn
- 2003-07-02 AU AU2003247404A patent/AU2003247404A1/en not_active Abandoned
- 2003-07-02 MX MXPA05000251A patent/MXPA05000251A/es unknown
- 2003-07-02 BR BR0312393-6A patent/BR0312393A/pt not_active IP Right Cessation
- 2003-07-02 CA CA002491372A patent/CA2491372A1/en not_active Abandoned
-
2004
- 2004-12-16 IL IL16581304A patent/IL165813A0/xx unknown
-
2005
- 2005-12-15 ZA ZA200410135A patent/ZA200410135B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2003247404A1 (en) | 2004-01-23 |
EP1531829A2 (en) | 2005-05-25 |
JP2005536490A (ja) | 2005-12-02 |
WO2004004634A2 (en) | 2004-01-15 |
KR20050077045A (ko) | 2005-07-29 |
IL165813A0 (en) | 2006-01-15 |
ZA200410135B (en) | 2006-07-26 |
CN1665516A (zh) | 2005-09-07 |
CA2491372A1 (en) | 2004-01-15 |
PL373219A1 (en) | 2005-08-22 |
MXPA05000251A (es) | 2005-07-15 |
WO2004004634A3 (en) | 2004-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0313282A (pt) | Composições de inibidor seletivo de ciclooxigenase-2 e um inibidor de anidrase carbÈnica para o tratamento de neoplasia | |
BRPI0510094A (pt) | uso de flibanserina no tratamento pré-menstrual e outros distúrbios sexuais femininos | |
BRPI0410927A (pt) | métodos terapêuticos e profiláticos para distúrbios neuromusculares | |
BR0010524A (pt) | Tratamento de tumores humanos refratários com antagonistas de receptor de fator de crescimento epidérmico | |
BRPI0418029A (pt) | formulação de anticorpos cd40 e métodos | |
BRPI0512213A (pt) | método para tratamento, prevenção ou melhora de uma doença ou distúrbio; composição farmacêutica; processo para a preparação de um composto; e uso de um composto | |
MX2010004074A (es) | Combinacion 059. | |
BRPI0512220A (pt) | método para tratamento, prevenção ou melhora de uma doença ou distúrbio; composição farmacêutica; processo para a preparação de um composto; e uso de um composto | |
MXPA05007822A (es) | Terapia de combinacion para tratar trastornos de la deficiencia de proteinas. | |
BRPI0313792B8 (pt) | utilização de proteína de eritropoetina, método para tratamento de distúrbios de distribuição de ferro em diabetes e medicamento para o seu tratamento | |
AU2003219107A8 (en) | Tuberculosis treatment using pleuromutilin derivatives | |
DE60327557D1 (de) | Verwendung von spongosin (2-methoxyadenosin) zur behandlung von schmerzen, insbesondere hyperalgesie | |
WO2004110380A3 (en) | Treatment of immune-mediated disorders with active vitamin d compounds alone or in combination with other therapeutic agents | |
BRPI0415781A (pt) | método para o tratamento de diabetes em um paciente e kit farmacêutico | |
BR0211830A (pt) | Dose única de azitromicina | |
BRPI0716929A8 (pt) | tratamento de esclerose múltipla com campath-1h | |
HK1074840A1 (en) | Novel dithiolopyrrolones with therapeutic activity | |
SI1501495T1 (sl) | Uporaba plevromutilinov za zdravljenje motenj, povzročenih s Helicobacter pylori | |
BR0312393A (pt) | Tratamento de infertilidade com exemestano | |
WO2003103699A8 (en) | USE OF RAMOPLANIN TO TREAT DISORDERS ASSOCIATED WITH THE TAKING OF ANTIBIOTICS | |
EA200600989A1 (ru) | Применение габоксадола для лечения бессонницы | |
ATE537838T1 (de) | Kombinationstherapie mit kloretazin(tm) | |
EP1143996A4 (en) | Method of treating chronic cardiac disease | |
BR0308753A (pt) | Método para produzir pseudo-ilhotas | |
TW200501958A (en) | A therapeutic agent for treating a behavioral disorder |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A,6A E 7A ANUIDADES |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2064 DE 27/07/2010. |